Skip to main content
. 2021 Jun 23;57(1):95–105. doi: 10.1097/SHK.0000000000001823

Fig. 3.

Fig. 3

Comparison of circulating endothelial biomarkers between worsening and not worsening non-ICU COVID-19 patients. Datapoints indicate individual measurements, whereas horizontal bars show median and interquartile ranges. C5b9 deposits are expressed as fold increase versus control. ADAMTS-13 indicates a disintegrin-like and metalloprotease with thrombospondin type 1 motif no. 13; NETs, neutrophil extracellular traps; PAI-1, plasminogen activator inhibitor-1; sC5b9: soluble C5b9; sTNF-RI, soluble tumor necrosis factor receptor I; sVCAM-1, soluble vascular cell adhesion molecule-1; VWF, Von Willebrand Factor.